TOP
Nav Bar
  1. General Info
  2. Effects Info
  3. Reference
Drug Interaction Details
01. General Information
Pair Name Ursolic acid, Sorafenib
Phytochemical Name Ursolic acid (PubChem CID: 64945 )
Anticancer drug Name Sorafenib (PubChem CID: 216239 )
Structure of
Phytochemical
2D-img
Download
2D MOL 3D MOL
Structure of
Anticancer Drug
2D-img
Download
2D MOL 3D MOL
02. Combinatorial Therapeutic Effect(s)
Synergistic Effect
Hide/Show
Enhancing Drug Efficacy
Hide/Show
Combination Pair ID: 1012
Pair Name Ursolic acid, Sorafenib
Disease Info [ICD-11: 2C12] Hepatocellular carcinoma Investigative
Biological Phenomena Induction-->Autophagy
Gene Regulation Down-regulation Expression MCL1 hsa4170
In Vitro Model Hep-G2 Hepatoblastoma Homo sapiens (Human) CVCL_0027
SMMC-7721 Human papillomavirus-related cervical adenocarcinoma Homo sapiens (Human) CVCL_0534
Huh-7 Adult hepatocellular carcinoma Homo sapiens (Human) CVCL_0336
H22 Hepatocellular carcinoma Mus musculus (Mouse) CVCL_H613
In Vivo Model To assess the inhibitory effect of different drugs on mouse liver cancer xenografts, six experimental groups of mice were  randomly  set up: (1) Control (saline), (2) UA (4 mg/kg), (3) Sora (4 mg/kg), (4) UA + Sora (UA 4 mg/kg, Sora 4 mg/kg), (5) US NPs (UA 4 mg/kg, Sora 4 mg/kg), (6) US NPs + rapamycin (UA 4 mg/kg, Sora 4 mg/kg), 6 mice in each group.
Result The carrier-free US NPs provide new strategies for HCC treatment and new ideas for the development of novel nano-drug delivery systems containing UA and Sora.
Combination Pair ID: 189
Pair Name Ursolic acid, Sorafenib
Disease Info [ICD-11: 2A00-2F9Z] Solid tumour or cancer Investigative
Biological Phenomena Induction-->Ferroptosis
Gene Regulation Up-regulation Expression BIM hsa10018
Up-regulation Expression CASP3 hsa836
Up-regulation Expression CASP8 hsa841
Up-regulation Expression CASP9 hsa842
Down-regulation Expression MCL1 hsa4170
Up-regulation Expression PARP1 hsa142
Up-regulation Expression ROS1 hsa6098
Down-regulation Expression SLC7A11 hsa23657
In Vitro Model HCT 116 Colon carcinoma Homo sapiens (Human) CVCL_0291
AGS Gastric adenocarcinoma Homo sapiens (Human) CVCL_0139
In Vivo Model HCT 116 cells (3×10⁶), HCT116 Vector cells (3×10⁶), HCT116 Mcl-1 overexpression cells (3×10⁶) and HCT116 SLC7A11 overexpression cells (3×10⁶) suspended in 0.2 ml of PBS were subcutaneously inoculated into the right flank of each mouse.
Result These results suggest that the synergistic antitumor effects of sorafenib combined with ursolic acid may involve the induction of Mcl-1-related apoptosis and SLC7A11-dependent ferroptosis. Our findings may offer a novel effective therapeutic strategy for tumor treatment.
03. Reference
No. Title Href
1 Synergistic anti-tumor effect of dual drug co-assembled nanoparticles based on ursolic acid and sorafenib. Colloids Surf B Biointerfaces. 2024 Feb;234:113724. doi: 10.1016/j.colsurfb.2023.113724. Click
2 Ursolic acid enhances the antitumor effects of sorafenib associated with Mcl-1-related apoptosis and SLC7A11-dependent ferroptosis in human cancer. Pharmacol Res. 2022 Aug;182:106306. doi: 10.1016/j.phrs.2022.106306. Click
It has been 46876 visits since 2024.08
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang
TOP